2.2050.00% ( 0.000 )
Delay Closed: Nov 16, 16:08:00Valuation
Current ValuationThe current P/E ratio is 8.29, within the reasonable range, cheaper than 42.15% of the time in the past 1 years, and the industry ranks 5/21, the industry Median 8.76.
8.29xP/E
HK$2.21Stock price
HK$0.27Earnings per share
8.29xP/E
Stock priceHK$2.21Earnings per shareHK$0.27
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 7.90x
- Typical range
- -13.92x–13.39x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 8.76x
024487296
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 8.76x
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
01515HKCR MEDICAL | 6.56x | 6.49% | HK$3.18B |
02219HKCHAOJU EYE CARE | 8.76x | 18.06% | HK$1.66B |
02677HKDISTINCT HEALTH | 8.71x | -- | HK$1.44B |
01526HKRICI HEALTH | 3.71x | -- | HK$1.27B |
02279HKYONGHE MEDICAL | 8.29x | 49.38% | HK$1.16B |
03689HKKANGHUA HEALTH | 5.43x | -- | HK$601.91M |
02135HKRAILY AESMED | 3.57x | -- | HK$55.71M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
